Search clinical trials for: ABT-143 (rosuvastatin calcium and fenofibric acid )

Total 2524 results

AstraZeneca

Completed

Assessment of the Effect of Food on ABT-143 Bioavailability

Pharmacokinetic Variables

United States
AstraZeneca

Completed

A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia

Dyslipidemia | Hypercholesterolemia

United States
AstraZeneca

Completed

30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease

Dyslipidemia | Kidney Disease

United States, Puerto Rico
AstraZeneca

Completed

Interaction Between ABT-335, Rosuvastatin and Warfarin

Healthy

United States
Abbott

Completed

A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia

Mixed Dyslipidemia

United States
Abbott

Completed

Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules

Healthy

United States
AstraZeneca

Completed

Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.

Adverse Events | Pharmacokinetic Variables

United States
AstraZeneca

Completed

Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium

Adverse Events | Pharmacokinetic

United States
AstraZeneca

Completed

Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium

Healthy

United States
AstraZeneca

Completed

Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg

Healthy

United States
Abbott

Completed

Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.

Dyslipidemia | Coronary Heart Disease | Mixed Dyslipidemia

United States
Abbott

Completed

A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe

Pharmacokinetics

United States
Essentialis, Inc.

Withdrawn

Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides

Hypertriglyceridemia
HK inno.N Corporation

Completed

To Compare Safety and Pharmacokinetic Properties of CJ-30039 and Lipidil Supra

Healthy

Korea, Republic of
Mutual Pharmaceutical Company, Inc.

Completed

Fasted Pharmacokinetic and Bioequivalency Study of Fenofibric Acid

Healthy
Daewoong Pharmaceutical Co. LTD.

Completed

Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers

Healthy

Korea, Republic of
Mutual Pharmaceutical Company, Inc.

Completed

Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate)

Healthy

United States
Mutual Pharmaceutical Company, Inc.

Completed

Fed Bioequivalence Study of Fenofibric Acid Versus TriCor® (Fenofibrate)

Healthy
University of Utah
Abbott

Terminated

Study of Trilipix Effects on Lipids and Arteries

Dyslipidemia

United States
University of Pennsylvania
University of Arizona; National Center for Advancing Translational Sciences... and other collaborators

Completed

FEnofibRate as a Metabolic INtervention for COVID-19 (FERMIN)

Covid19

United States
Abbott

Completed

Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood

Dyslipidemia | Coronary Heart Disease | Mixed Dyslipidemia

United States
Mutual Pharmaceutical Company, Inc.

Completed

Four Arm Food Effect Study of Fenofibric Acid Tablets

Healthy

United States
AstraZeneca

Completed

Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly

Dyslipidemia, Renal Insufficiency

United States
Hanmi Pharmaceutical Company Limited

Completed

Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 Capsule

Healthy

Korea, Republic of
Kobe University

Completed

Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial

Coronary Artery Disease Progression
Idorsia Pharmaceuticals Ltd.

Completed

A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin

Healthy Subjects

Czechia
Chong Kun Dang Pharmaceutical

Completed

CKD-337(2) Drug-drug Interaction Study

Healthy

Korea, Republic of
Makerere University
University of Oxford; Case Western Reserve University

Unknown

Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial (STAR)

HIV Infection
NVP Healthcare

Completed

to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers (NVP-1205)

Healthy
Idorsia Pharmaceuticals Ltd.

Completed

A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)

Healthy Subjects

Czechia
Nanjing First Hospital, Nanjing Medical University

Unknown

Early Vascular Healing in Acute Coronary Syndrome Patients With Different Doses of Rosuvastatin (CROWN-1)

Acute Coronary Syndrome

China
Shanghai Zhongshan Hospital

Unknown

Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With Non ST-segment Elevated Acute Coronary Syndrome(NSTE-ACS)

Non-ST-elevation Acute Coronary Syndromes

China
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Statin and Atheroma Vulnerability Evaluation (STABLE)

Coronary Artery Disease

Korea, Republic of
University of Roma La Sapienza

Unknown

Rosuvastatin for Preventing Complications in Renal Ablation (ARTEMISIA)

Arterial Hypertension

Italy
Sang Hak Lee

Unknown

Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid (AVOCADO)

Mixed Hyperlipidemia

Korea, Republic of
Cross Research S.A.
Zambon SpA

Completed

Safinamide Steady State Interaction With Rosuvastatin

Healthy

Switzerland
AstraZeneca

Completed

An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia

Familial Hypercholesterolaemia

United States, Netherlands, Norway, Canada, Belgium
AbbVie (prior sponsor, Abbott)

Completed

Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood (FIRST)

Coronary Artery Disease | Dyslipidemia | Coronary Heart Disease

United States
Ottawa Hospital Research Institute

Unknown

StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study (SAVER)

Venous Thromboembolism

Canada, Norway
EMS

Recruiting

Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

Dyslipidemia Associated With Type II Diabetes Mellitus

Brazil
AstraZeneca

Completed

A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)

Coronary Arteriosclerosis

United States, Australia, France, Italy, Spain, Belgium, Canada, Netherlands
National Institute of Diabetes and Digestive and...
National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Cancer... and other collaborators

Recruiting

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (LCN RESCU)

Cirrhosis | Cirrhosis, Liver | Cirrhosis Due to Hepatitis B | Cirrhosis Due to Hepatitis C | Cirrhosis Early | Cirrhosis Advanced | Cirrhosis Infectious | Cirrhosis Alcoholic | Cirrhosis, Biliary | Cirrhosis Cryptogenic | Cirrhosis Due to Primary Sclerosing Cholangitis

United States
Asahi Kasei Pharma Corporation

Completed

Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer

Postoperative Stage II/III Colon Cancer

Japan
Bristol-Myers Squibb

Completed

Drug Interaction Study With Rosuvastatin

Immunosuppression For Disease

United States
AstraZeneca

Completed

A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)

Hypercholesteremia

United States, France, Norway, Netherlands, Belgium, Germany, Finland, Czech Republic
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

Pain | Breast Cancer | Lung Cancer | Prostate Cancer | Metastatic Cancer

United States
EMS

Not yet recruiting

Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia

Type 2 Diabetes Mellitus | Dyslipidemia
University of Miami

Terminated

Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma

Multiple Myeloma

United States
Alvogen Korea

Completed

Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy

Hypertension | Cholesterolemia

Korea, Republic of
GlaxoSmithKline

Completed

Rosuvastatin Calcium Bioequivalence Study - Fast

Hypercholesterolaemia

Brazil

3

Subscribe